These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8566162)

  • 41. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
    Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
    J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rational drug design and synthesis of a highly selective nonpeptide delta-opioid agonist, (4aS*,12aR*)-4a-(3-hydroxyphenyl)-2-methyl- 1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine (TAN-67).
    Nagase H; Kawai K; Hayakawa J; Wakita H; Mizusuna A; Matsuura H; Tajima C; Takezawa Y; Endoh T
    Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1695-702. PubMed ID: 9845952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
    Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
    Ioja E; Tóth G; Benyhe S; Tourwe D; Péter A; Tömböly C; Borsodi A
    Neurosignals; 2005; 14(6):317-28. PubMed ID: 16772734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
    Clark MJ; Emmerson PJ; Mansour A; Akil H; Woods JH; Portoghese PS; Remmers AE; Medzihradsky F
    J Pharmacol Exp Ther; 1997 Nov; 283(2):501-10. PubMed ID: 9353363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of delta opioid receptor function by up-regulation of membrane receptors in mouse primary afferent neurons.
    Walwyn W; Maidment NT; Sanders M; Evans CJ; Kieffer BL; Hales TG
    Mol Pharmacol; 2005 Dec; 68(6):1688-98. PubMed ID: 16135785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of optically active TAN-67, a highly selective delta opioid receptor agonist, and investigation of its pharmacological properties.
    Fujii H; Kawai K; Kawamura K; Mizusuna A; Onoda Y; Murachi M; Tanaka T; Endoh T; Nagase H
    Drug Des Discov; 2001; 17(4):325-30. PubMed ID: 11765135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function.
    Brasel CM; Sawyer GW; Stevens CW
    Eur J Pharmacol; 2008 Dec; 599(1-3):36-43. PubMed ID: 18930720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a series of N-alkyl benzomorphans in cell lines expressing transfected delta- and mu-opioid receptors.
    Abood ME; Noel MA; Carter RC; Harris LS
    Biochem Pharmacol; 1995 Sep; 50(6):851-9. PubMed ID: 7575648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutation W284L of the human delta opioid receptor reveals agonist specific receptor conformations for G protein activation.
    Hosohata Y; Varga EV; Stropova D; Li X; Knapp RJ; Hruby VJ; Rice KC; Nagase H; Roeske WR; Yamamura HI
    Life Sci; 2001 Apr; 68(19-20):2233-42. PubMed ID: 11358332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands.
    Shenderovich MD; Liao S; Qian X; Hruby VJ
    Biopolymers; 2000 Jun; 53(7):565-80. PubMed ID: 10766952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
    Emmerson PJ; Liu MR; Woods JH; Medzihradsky F
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and evaluation of N,N-dialkyl enkephalin-based affinity labels for delta opioid receptors.
    Maeda DY; Ishmael JE; Murray TF; Aldrich JV
    J Med Chem; 2000 Oct; 43(21):3941-8. PubMed ID: 11052799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-Desmethylclozapine, a major clozapine metabolite, acts as a selective and efficacious delta-opioid agonist at recombinant and native receptors.
    Onali P; Olianas MC
    Neuropsychopharmacology; 2007 Apr; 32(4):773-85. PubMed ID: 16841075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes.
    Onali P; Dedoni S; Olianas MC
    J Pharmacol Exp Ther; 2010 Jan; 332(1):255-65. PubMed ID: 19828880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP; Leone P; Pocock D; Wise RA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
    Shook JE; Pelton JT; Lemcke PK; Porreca F; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of peptide and nonpeptidic agonists at the cloned human delta opioid receptor.
    Knapp RJ; Waite S; Landsman R; Santoro G; De Leon IA; Malatynska E; Varga E; Nagase H; Calderon SN; Rice K
    Proc West Pharmacol Soc; 1995; 38():141-3. PubMed ID: 7480008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.